Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ resapp health limited

2020 commercialisation, page-602

First 602 Last

Share
Profile

Follow
Arthurgang

200 Posts.

31

19/11/20

12:26

Post #: 48987524
Share

Originally posted by Dacca: ↑

Hi Largeraj,
I have often thought about this as well and would like to know where they are at with these further discussions with FDA, that they mentioned would be ongoing to work through the issues that led to it no being approved (I think they stated a 30-60 day timeframe for their subsequent meeting?)?

I understand that they are now focussing on penetration into other countries markets, and I am happy that they are taking that approach; however I feel that there should still be updates about their discussion, and if they have even had that meeting at all?! That seems like price sensitive information to me..!?! Some sort of update, any update; did the meeting occur, was it postponed, did the FDA list the "dangers" they had, to we need to start from scratch or amend our submission.?

I just feel like this has all been forgotten about, and the only reason I can think that they wouldn't update us on this is that the news is bad.. Hoping not, but a simple update would be what us shareholders deserve, whatever the outcome, for better or worse..

Expand

Dacca

I totally agree about the FDA as some holders are only hanging around for further news and hope.

If there has been talks we should at least be informed (better or worse) if not management are once again pulling the wool over our eyes. IMO

RAP Price at posting: 9.2¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

BYH

Bryah gains $408K government rebate for work on copper target Narracoota

IVR

Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage

WC8

Leia pegmatite pulls up recoveries of 84% lithium for Wildcat in WA

AI stocks: What to expect in 2024-25

Talking the US election, the spectre of Trump and what's hot on the ASX200: Wealth Within